EDGAR·FLOW

enVVeno Medical Corp — Form 8-K

Filed July 14, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 5/100
What the filing says
enVVeno Medical Corp (market cap ~$76.1M) filed an 8-K on July 14, 2026 containing Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes 25 graphic files and exhibits but the actual text content of the disclosure is not provided in the filing document index—only metadata, file names, and XBRL data files are visible. No specific dollar amounts, counterparties, dates, percentages, or business changes can be determined from the available text.
Why this rating

Routine 8-K filing with standard disclosure format; substantive content not accessible in provided text; cannot assess materiality without disclosure details.

Extracted items
View original filing on SEC.gov ↗ NVNO · stock on Yahoo Finance ↗

See more from July 14, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.